Summary
Despite a rising worldwide epidemic of obesity there is currently only a very small number of anti-obesity drugs available to manage the problem. Large numbers of differing pharmacological agents reliably produce a reduction in food intake when administered acutely to animals, and when administered chronically they result in a significant decrease in body mass. Behavioural analysis of drug-induced anorexia in animals demonstrates that various compounds profoundly effect feeding behaviour in differing ways. This indicates the variety of mechanisms by which pharmacological agents can induce changes in food intake, body weight and eventually body composition. Some of the same drugs produce decreases in food intake and weight loss in humans. Some of these drugs do so by modifying the functioning of the appetite system as measured by subjective changes in feelings of hunger and fullness (indices of satiety). Such drugs can be considered as “appetite suppressants” with clinical potential as anti-obesity agents. Other drugs induce changes in food intake and body weight through various physiological mechanisms inducing feelings of nausea or even by side effect related malaise. Of the drugs considered suitable candidates for appetite suppressants are agents which act via peripherally satiety peptide systems (such as CCK, Bombesin/GRP, Enterostatin and GLP-1), or alter the CNS levels of various hypothalamic neuropeptides (NPY, Galanin, Orexin and Melanocortins) or levels of the key CNS appetite monoamine neurotransmitters such as serotonin (5-HT) and noradrenaline (NA). Recently, the hormone leptin has been regarded as a hormonal signal linking adipose tissue status with a number of key central nervous system circuits. The peptide itself stimulates leptin receptors and it links with POMC and MC-4 receptors. These receptors may also provide drug targets for the control of appetite. Any changes induced by a potential appetite suppressant should be considered in terms of the (i) psychological experience and behavioural expression of appetite, (ii) metabolism and peripheral physiology, and (iii) functioning of CNS neural pathways. In humans, modulation of appetite may involve changes in total caloric consumption, subjective changes in feelings of hunger and fullness, preferences for specific food items, and general macronutrient preferences. These may be expressed behaviourally as changes in meal patterns, snacking behaviour and food choice. Within the next 20 years it is certain that clinicians will have a new range of anti-obesity compounds available to choose from. Such novel compounds may act on a single component of the appetite system or target a combination of these components detailed in this review. Such compounds used in combination with lifestyle changes and dietary intervention may be useful in dealing with the rising world epidemic of obesity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blundell J.E.: Trends Pharmacol. Sci.12147–157 (1991).
Gibbs J., Young R. and Smith G.P.: J. Comp. Physiol.84488–493 (1973).
Gibbs J., Falasco J.D. and McHugh P.R.: Am. J. Physiol.23012–18 (1976).
Antin J., Gibbs J., Holt J., Young R.C. and Smith G.P.: J. Comp. Physiol. Psychol.89784–790 (1975).
Dourish C.T., Rycroft W. and Iversen S.D.: Science2451509–1511 (1989).
Moran T.H. and Schwatz GJ.: Crit. Rev. Neurobiology.91–28 (1994).
Kissileff H.R., Pi-Sunyer X., Thornton J. and Smith G.P.: Am. J. Clin. Nutr.34154–160 (1981).
Greenough A., Cole G., Lewis J., Lockton A. and Blundell J.: Physiol. Behay.64(1999, in press).
Hopman W.P.M., Jansen J.B. and Lamers C.B.: Scand. J. Gastroenterol.20843–847 (1985).
Moran T.H., Baldessarini A.R., Salorio C.F., Lowery T. and Schwartz GJ.: Amer. J. Physiol.41R1245–R1251 (1997).
Corp E.S., Curcio M., Gibbs J. and Smith G.P.: Physiol. & Behay.61823–827 (1997).
Brenner L.A. and Ritter R.C.: Physiol. & Behay.63711–716 (1998).
Dorre D. and Smith G.P.: Physiol. Behay.651–14 (1998).
Esfanhani N., Bedner I., Quershi G.A. and Sodersten P.: Biochem and Behay.519–12 (1995).
Voigt J.P., Sohr R. and Fink H.: Pharm. Biochem. Behay.59179–182 (1998).
Gibbs J., Fauser E.A., Rowe B.J., Rolls E.T and, Maddison S.P.: Nature282208–210 (1979).
Smith J., Perez S., Rushing P.A., Smith G.P. and Gibbs J.: Peptides181465–1467 (1997).
Stuckley J.A. and Gibbs J.: Brain Res. Bull.8617–621 (1982).
Stratford T.R., Gibbs J. and Smith G.P.: Peptides17107–110 (1996).
Flynn F.W.: Physiol & Behav62791–798 (1997).
McCoy J.G. and Avery D.D.: Peptides11595–697 (1990).
Plamondon H. and Merali Z.: Amer. J. Physiol.41R268–R274 (1997a).
Plamondon H. and Merali Z.: Eur. J. Pharmacol.34099–109 (1997b).
Lieverse RJ., Mascle A.A.M., Jansen J.B.M.J., Lam W.F. and Lamers C.B.H.W.: Eur. J. Clin. Nutr.52207–212 (1998).
Erlanson-Ablertsson C., Mei J., Okada S., York D.A. and Bray G.A.: Physiol. Behay.491191–1194 (1991).
Okada S., York D.A., Bray G.A., Erlanson-Albertsson C.: Physiol. Behay.491185–1189 (1991).
Mei J. and Erlanson-Albertsson C.: Obes. Res.4161–165 (1996).
Lin L. and York D.A.: Amer. J. Physiol.44R619–R623 (1998a).
Erlanson-Ablertsson C. and Larsson A.: Regul. Pept.22325–331 (1988).
Lin L., McClanahan S., York D.A. and Bray G.A.: Physiol. Behay.53789–794 (1993).
Lin L. and York D.A.: Peptides19557–562 (1998b).
Lin L. and York D.A.: Brain Res.745205–209 (1997a).
Shargill N.S., Tsujii S., Bray G.A., Erlanson-Albertsson C.: Brain Res.544137–140 (1991).
Lin L. and York D.A.: Peptides181341–1347 (1997b).
Turton M.D., O’Shea D., Gunn I., Beak S.A., Edwards C.M.B., Meeran K., Choi S.J., Taylor G.M., Heath M.M., Lambert P.D. et al.: Nature3796560,69–72 (1998).
Tang-Christensen M., Larsen P.J. and Goke R.: Am. J. Physiol.271R848–R856 (1996).
Rowland N.E. and Kalra S.P.: CNS Drugs7419–426 (1997).
McMahon L.R. and Wellman P.J.: Amer. J. Physiol.43R23–R29 (1998).
Hwa J.J., Ghibaudi L., Williams P., Witten M.B., Tedesco R. and Strader C.D.: Peptides19869–875 (1998).
Meeran K., O’Shea D., Edwards C.M.B., Turton M.D., Heath M.M., Gunn I., Abusnana S., Rossi M., Small CJ., Goldstone A.P. and Taylor G.M.: Endocrinology140244–250 (1999).
Lavin J.H., Wittert G.A., Andrews J., Yeap B., Wishart J.M., Morris H.A., Morley J.E., Horowitz M. and Read N.W.: Amer. J. Clin. Nutr.683 (1998).
Naslund E., Gutniak M., Skogar S., Rossner S. and Hellstrom P.M.: Amer. J. Clin. Nutr.683 (1998).
Gutzwiller J.P., Goke B., Drewe J., Hildebrand P., Ketterer S., Handschin D., Winterhalder R., Conen D. and Beglinger C.: Gut4481–86 (1999).
Blundell J.E.: Int. J. Obes.115–42 (1977).
Blundell J.E. and Halford J.C.G.: CNS Drugs9473–495 (1998).
Blundell J.E.: Am. J. Clin. Nutr.551555–1595 (1992).
Halford J.C.G., Wanninayake S.C.D. and Blundell J.E.: Pharmacol. Biochem. Behay.61159–168 (1998).
Tecott L.H., Sum L.M. and Akana S.F.: Nature374542–546 (1995).
Walsh A.E., Smith K.A. and Oldman A.D.: Psychopharmacology116120–122 (1994).
Sargent RA., Sharpley A.L. and Williams C.: Psychopharmacology133309–312 (1997).
Bodies S., Williams C. and Campling GM.: Psychopharmacology129179–182 (1997).
Hutson P.H., Donohoe T.P. and Curzon G.: Psychopharmacology97550–552 (1988).
Fletcher P.J. and Coscina D.V.: Pharmacol. Biochem. Behay.46487–491 (1993).
Coscina D.V., Feifel D., Norbrega J.N.: Am. J. Physiol.266R1562–R1567 (1994).
Dryden S., Wang Q. and Frankish H.M.: Brain Res.69912–18 (1995).
Dryden S., Frankish H.M. and Wang Q.: Brain Res.724232–237 (1996).
Dryden S., Frankish H.M. and Wang Q.: Neuroscience72557–566 (1996).
Fernstorm J.D.: Appetite8163 (1987).
Blundell J.E., Lawton C.L. and Halford J.C.G.: Obesity Res.3471–476 (1995).
Smith B.K., York D.A. and Bray G.A.: Pharmacol. Biochem. Behay.60105 (1998a).
Smith B.K., York DA. and Bray G.A.: Am. J. Physiol. (1999, in press)
Halford J.C.G., Smith B.K. and Blundell J.E.: In: Neural Control of Macronutrient Selection (1999).
Leibowitz S.F.: Pharmacol. Biochem. Behay.8163–175 (1978).
Leibowitz S.F.: Neurosci. Biobehay. Rev.12101–109 (1988).
Angel I.: Clin. Neuropharmacol.13361–391 (1990).
Wellman P.J.: Am. J. Clin. Nutr.55193s-198s (1992).
Wellman P.J., Davies B.T., Morien A. and McMahon L.: Life Sciences53669–679 (1993).
Wellman P.J., McMahon L.R., Green T. and Tole A.: Pharmacol. Biochem. Behay.57281–284 (1997).
Heal DJ., Aspley S., Prow M.R., Jackson H.C. and Cheetham S.C.: Int. J. Obesity22(1), s18-s28 (1998).
Jackson H.C., Nearham M.C., Hutchins L., Mazurkiewicz S.E., Needham A.M., Heal DJ.: Brit. J. Pharmacology1211613–1618 (1997).
Halford J.C.G., Heal D.J. and Blundell J.E.: Br. J. Pharamcology114378p (1995).
Terry P., Gilbert D.B. and Cooper S.J.: Obes. Res.3s515-s524 (1995).
Phillips G.D., Howes S.R., Whitelaw R.B., Robbins T.W. and Everitt B.J.: Psychopharmacology11782–90 (1995).
Cincotta A.H. and Meier A.H.: Diabetes Care19667–679 (1996).
Dryden S. and Williams G.: Curr. Opin. Endo. Diab.351–58 (1996).
Bivens C.L.M., Thomas W.J. and Stanley B.G.: Brain Res.782271–280 (1998).
Grignaschi G., Sironi F. and Samanin R.: Eur. J. Pharmacol.274221–224 (1995).
Currie P.J. and Coscina D.V.: Neuroreport83759–3762 (1997).
Currie P.J. and Coscina D.V.: Brain Res.803212–217 (1998).
Schwartz M.W., Marks J., Sipols A.J., Baskin D.B., Wood S.C., Kahn S.E. and Porte J.D.: Endocrinology1282645–2647 (1991).
Schwartz M.W., Figlewicz D.P., Baskin D.G., Woods S.C., Kahn S.E. and Porte J.D.: Endocrine Rev.2109–113 (1994).
Woods S.C., Seeley R.J., Porte D. and Schwartz M.W.: Science2801378–1383 (1998).
Erickson J.C., Clegg K.E. and Palmiter R.D.: Nature381415–418 (1996).
Erickson J.C., Hollopetter G. and Palmiter R.D.: Science2741704–1707 (1996).
Smith F.J., Campfield L.A., Moschera J.A., Bailon P.S. and Burn P.: Reg. Peptides.75433–439 (1998).
Schwartz M.W., Seeley R.J., Campfield L.A., Burn P. and Baskin D.G.: J. Clin. Inv.981101–1106 (1996).
Sahu A.: Endocrin.139795–798 (1998).
Sahu A.: Endocrin.1394739–4742 (1998).
Balashubramaniam A.: Peptides18445–457 (1997).
Lopez-Valpuesta F.J., Nyce J.W. and Myers R.D.: Neuroreport72781–2784 (1996).
Kask A., Rago L and Harro J.: Brit. J. Pharmacol.1241507–1515 (1998).
Wieland H.A., Engel W., Eberlein W., Rudolf K., Doods H.N.: Brit. J. Pharmacol.125549–560 (1998).
Marsh D.J., Hollopeter G., Kafer K.E. and Palmiter R.D.: Nature Medicine4718–721 (1998)
Tang-Christensen M., Kristensen P., Stidsen C.E., Brand C.L. and Larsen P.J.: Endocrin.159307–312 (1998).
Leibowitz S.F. and Alexander J.T.: Peptides121251–1260 (1991).
Hollopeter G., Erickson J.C. and Palmiter R.D.: Int. J. Obes.22506–512 (1998).
Woldbye D.P.D. and Larsen P.J.: Nature Medicine4(6), 671–672 (1998).
Kalra P.S., Dube M.G., Xu B. and Kalra S.P.: Reg. Peptides72121–130 (1997).
Stricker-Krongrad A., Kozak R., Burlet C., Nicolas J.P. and Beck B.: Amer. J. Physiol.43R2112–R2116 (1997).
Ishihara A., Tanaka T., Kanatani A., Fukami T., Ihara M. and Fukuroda T.: Amer. J. Physiol.43R1500–R1504 (1998).
Roche C., Boutin P., Dina C., Gyapay G., Basdevent A., Hager J., Guy-Grand B., Clement K. and Froguel: Diabetologic40671–675 (1997).
Leibowitz S.F.: Obes. Res.3(suppl 4), 573–589s (1995).
Leibowitz S.F., Akabayashi A., Alexander J.T. and Wang J.: Endocrinol.1391771–1780 (1998).
Lin L., York D.A. and Bray G.A.: Obes. Res.4117–123 (1996).
Koegler F.H. and Ritter S.: Obes. Res.4329–336 (1996).
Koegler F.H. and Ritter S.: Physiol. Behay.63521–527 (1998).
Menzaghi F., Heinrichs S.C. and Pich E.M.: Brain Res.61876–82 (1993).
Gardner J.D., Rothwell N.J. and Luheshi G.N.: Nature Neurosci.1103 (1998).
Spina M., Merlo-Pich E., Chan R.K.W., Basso A.M., Rivier J., Vale W. and Koob G.F.: Science273(5281), 1561–1564 (1996).
Smagin G.N., Howell L.A., Ryan D.H., DeSouza E.B. and Harris R.B.S.: Neurorep.71601–1606 (1998).
Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S. et al.: Cell92573–585 (1998).
van den Pol A.N., Gao X.B., Obrietan K., Kilduff T.S. and Belousov A.B.: J. Neurosci.187962–7971 (1998).
Trivedi P., Yu H., MacNeil D.J., Vander Ploeg L.H.T. and Guan X.M.: FEBS Letters43871–75 (1998).
Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G. and Kilduff T.S.: J. Neurosci.189996–10015 (1998).
Edwards C.M.B., Abusnana S., Sunter D., Murphy K.G., Ghatel M.A. and Bloom S.R.: J. Endocrinology160R7–R12 (1999).
Ludwig D.S., Mountjoy K.G., Tatro J.B., Gillette J.A., Frederich R.C., Flier J.S. and MaratosFlier E.: Amer. J. Physiol.37E627–E633 (1998).
Hagan M.M., Rushing P.A., Schwartz M.W., Yagaloff K.A., Burn P., Woods S.C. and Seeley R.J.: J. Neurosceince192362–2367 (1999).
Mizuno T.M., Kleopoulos S.P., Bergen H.T., Roberts J.L., Priest C.A. and Mobbs C.V.: Diabetes47294–297 (1998).
Fisher S.L., Yagaloff K.A. and Burn P.: Int. J. Obesity23s54-s58 (1999).
Kiefer L.L., Ittoop O.R.R., Bunce K., Truesdale A.T., Willard D.H., Nichols J.S., Blanchard S.G., Mountjoy K., Chen W.J. and Wilkison W.O.: Biochemistry362084–2090 (1997)
Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D. et al.: Cell88131–141 (1997).
Fan W., Boston B.A., Kesterson R.A., Hruby V.J. and Cone R.D.: Nature3856612, 165–168 (1997).
Krude H., Biebermann H., Luck W., Horn R., Brabant G. and Gruters A.: Nature Genetics19155–157 (1998).
Giraudo S.Q., Billington C.J. and Levine AS.: Brain Res.809302–306 (1998).
Grill HJ., Ginsberg A.B., Seeley R.J. and Kaplan J.M.: J. Neuroscience1810128–10135 (1998).
Skuladottir G.V., Jonsson L., Skarphedinsson J.O., Mutulis F., Muceniece R., Raine A., Mutule I., Helgason J., Prusis P., Wikberg J.E.S. and Schioth H.B.: Brit J. Pharmacol.12627–34 (1999).
Kask A., Rago L., Korrovits P., Wikberg J.E.S. and Schioth H.B.: Biochem. Biophys. Res. Com.248245–249 (1998).
Kask A., Rago L., Wikberg J.E.S. and Schioth H.B.: Eur. J. Pharmacol.36015–19 (1998).
Colombo G., Agabio R., Diaz G., Lobina C., Reali R. and Gessa G.L.: Life Sci.63113–117 (1998).
Kristenbesen P., Judge ME., Thim L., Ribel U., Christjansen K.N., Wulff B.S., Clausen J.T., Jensen P.B., Madsen O.D., Vrang N., Larsen P.J. and Hastrup S.: Nature39372–76 (1998).
Lambert P.D., Couceyro P.R., McGirr K.M., Vechia S.E.D., Smith Y. and Kuhar M.J.: Synapse29293–298 (1998).
Vrang N., Tang Christensen M., Larsen P.J. and Kristensen P.: Brain Res.818499–509 (1999).
Kennady J.C.: Proc. R. Soc. London (Biol.)140578 (1953).
Mohamed-Ali V., Pinkney J.H. and Coppack S.W.: Int. J. Obes.221145–1158 (1998).
Zhang Y., Proenca R., Maffei M., Barone M. and Friedman J.M.: Nature372425–432 (1994)
Pelleymounter M.A., Cillen M.J., Baker M.B., Hecht R., Winters D., Boone T. and Collins F.: Science269540–543 (1995).
Halaas J.L., Gajiwala K.S., Maffei M., Cohen S.L., Chati B.T., Rabiowitx D., Lallone R.L., Burley S.K. and Friedman J.M.: Science269543–546 (1995).
Campfield L.A., Smith F.J., Guisez Y., Devos R. and Burn P.: Science269546–549 (1995).
Chen H., Charlet O., Tartaglia L.A., Woolf E.A., Weng X., Ellis S.J., Lakey N.D., Culpapper J., Moore K.J., Breibart R.F. et al.: Cell84491–495 (1996).
Lee G., Proenca R., Montez J.M., Carrol K.M., Darvishzadeh J.G., Leed J.I. and Freidman J.M.: Nature379632–635 (1996).
Campfield L.A. and Smith F.J.: Proc. Nutr. Soc.57429–440 (1998).
Coppack S.W., Pinkney J.H. and Mohamed-Ali V.: Proc. Nutr. Soc.57461–470 (1998).
Maffei M., Halaas J., Ravussin E., Partley R.E., Lee G.H., Zhang Y., Fei H., Kim S., Lallone R., Ranganathan S., Kern P.A. and Friedman J.M.: Nature Medicine11155–1161 (1995).
Considine R.V., Sinda M.K., Heiman M.L., Kriauciunas A., Stephens T.W., Nyce M.R., Ohannesian J.P., Marco C.C., McKee L.J., Baur T.L. and Caro J.F.: N. Engl. J. Med.334292–295 (1996).
Montague C.T., Farooqi I.S., Whitehead J.P., Soos M.A., Rau H., Wareham NJ., Sewter C.P., Digby J.E., Mohammed S.N., Hurst J.A. et al.: Nature387903–908 (1997).
Drent M.L. and van der Veen E.A.: Obes. Res.3S623–S625 (1995).
James W.P.T., Avenell A., Broom J. and Whitehead J.: Int. J. Obes.21S24–S30 (1997).
Van Gaal L.F., Broom J.I., Enzi G. and Toplak H.: Eur. J. Clin. Pharmacol.54125–132 (1998).
Davidson M.H., Hauptman J., Di Girolamo M., Foreyt J.P., Halsted C.H., Heber D., Heimburger D.C., Lucas C.P., Robbins D.C., Chung J. and Heymsfield S.B.: JAMA281235–242 (1999).
McNeely W. and Benfield P.: Drugs56241–249 (1998).
Sjostrom L., Rissen A., Anderson T., Boldrin M., Golay A., Koppeschaar H.P.F. and Kempf M.: Lancet352167–172 (1998).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Basel AG
About this chapter
Cite this chapter
Halford, J.C.G., Blundell, J.E. (2000). Pharmacology of appetite suppression. In: Jucker, E. (eds) Progress in Drug Research. Progress in Drug Research, vol 54. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8391-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8391-7_2
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9546-0
Online ISBN: 978-3-0348-8391-7
eBook Packages: Springer Book Archive